Show simple item record

FieldValueLanguage
dc.contributor.authorPatel, A
dc.contributor.authorWebster, R
dc.date.accessioned2019-09-11
dc.date.available2019-09-11
dc.date.issued2016-03-01
dc.identifier.citationPatel, A., & Webster, R. (2016). Pragmatic Trials for Noncommunicable Diseases: Relieving Constraints. PLOS Medicine, 13(3), e1001986. https://doi.org/10.1371/journal.pmed.1001986en_AU
dc.identifier.urihttp://hdl.handle.net/2123/21099
dc.description.abstractAt the 65th World Health Assembly in 2012, all World Health Organization member states made a historic commitment to reduce premature deaths from noncommunicable diseases (NCDs, including cardiovascular diseases, diabetes, cancer, and chronic respiratory diseases) by 25% by 2025. Subsequently, the World Health Assembly in 2013 agreed to adopt a global monitoring framework that included nine ambitious global NCD targets for 2025 [1]. These targets address key risk factors including tobacco and alcohol use, physical inactivity, high salt intake, high blood pressure, diabetes, and obesity and also the availability of basic technologies and medicines for the prevention and treatment of major NCDs.en_AU
dc.language.isoen_AUen_AU
dc.publisherPublic Library of Scienceen_AU
dc.relationn/aen_AU
dc.titlePragmatic Trials for Noncommunicable Diseases: Relieving Constraintsen_AU
dc.typeArticleen_AU
dc.identifier.doi10.1371/journal.pmed.1001986
dc.type.pubtypePublisher versionen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.